• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

QuantiFERON 监测可预测异基因造血干细胞移植后早期巨细胞病毒感染和病毒载量。

QuantiFERON monitor predicts early cytomegalovirus infection and viral burden in allogeneic hematopoietic stem cell transplantation.

机构信息

Department of Laboratory Medicine and Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, South Korea.

Department of Laboratory Medicine, Inje University Ilsan Paik Hospital, Goyang, South Korea.

出版信息

Transpl Infect Dis. 2024 Aug;26(4):e14328. doi: 10.1111/tid.14328. Epub 2024 Jul 9.

DOI:10.1111/tid.14328
PMID:38980949
Abstract

INTRODUCTION

Cytomegalovirus (CMV) infection is a major cause of transplantation-related morbidity and mortality. This study assessed the utility of the QuantiFERON monitor (QFM; Qiagen) for the prediction of early CMV infection and viral burden.

METHODS

QuantiFERON-CMV (QF-CMV; Qiagen) and QFM were measured at the post-allogeneic hematopoietic stem cell transplantation (HSCT) week 4. CMV DNA was measured at every visit until post-HSCT week 24. The QFM cutoff specific to CMV infection was established.

RESULT

At the post-HSCT week 4, the QFM cutoff predicting CMV infection was 86.95 IU/mL. While QF-CMV results at the post-HSCT week 4 were associated with high-level CMV infection (CMV DNA ≥ 5,000 IU/mL) but not with CMV infection (CMV DNA ≥ 500 IU/mL), QFM was associated with both CMV infection and high-level CMV infection. Both indeterminate QF-CMV and nonreactive QFM were associated with increased peak CMV DNA.

CONCLUSION

Low QFM is a risk factor for CMV infection and increased CMV viral loads. QFM at post-HSCT week 4 can be utilized as an assay to predict the risk and burden of early CMV infection in HSCT recipients, in conjunction with other risk factors.

摘要

简介

巨细胞病毒 (CMV) 感染是移植相关发病率和死亡率的主要原因。本研究评估了 QuantiFERON 监测器 (QFM;Qiagen) 在预测早期 CMV 感染和病毒载量方面的效用。

方法

在异基因造血干细胞移植 (HSCT) 后第 4 周测量 QuantiFERON-CMV (QF-CMV;Qiagen) 和 QFM。在 HSCT 后第 24 周之前,每次就诊时都测量 CMV DNA。建立针对 CMV 感染的 QFM 截止值。

结果

在 HSCT 后第 4 周,预测 CMV 感染的 QFM 截止值为 86.95 IU/mL。虽然 HSCT 后第 4 周的 QF-CMV 结果与高水平 CMV 感染(CMV DNA ≥ 5,000 IU/mL)相关,但与 CMV 感染(CMV DNA ≥ 500 IU/mL)无关,而 QFM 与 CMV 感染和高水平 CMV 感染均相关。不确定的 QF-CMV 和非反应性 QFM 均与 CMV DNA 峰值增加相关。

结论

低 QFM 是 CMV 感染和增加 CMV 病毒载量的危险因素。HSCT 后第 4 周的 QFM 可与其他危险因素一起用作预测 HSCT 受者早期 CMV 感染风险和负担的检测方法。

相似文献

1
QuantiFERON monitor predicts early cytomegalovirus infection and viral burden in allogeneic hematopoietic stem cell transplantation.QuantiFERON 监测可预测异基因造血干细胞移植后早期巨细胞病毒感染和病毒载量。
Transpl Infect Dis. 2024 Aug;26(4):e14328. doi: 10.1111/tid.14328. Epub 2024 Jul 9.
2
Clinical Usefulness of Monitoring Cytomegalovirus-Specific Immunity by Quantiferon-CMV in Pediatric Allogeneic Hematopoietic Stem Cell Transplantation Recipients.通过全血γ干扰素释放试验监测巨细胞病毒特异性免疫在儿科异基因造血干细胞移植受者中的临床应用价值
Ann Lab Med. 2017 May;37(3):277-281. doi: 10.3343/alm.2017.37.3.277.
3
QuantiFERON-CMV and monitor predict cytomegalovirus, mortality, and graft-versus-host disease in transplant recipients.QuantiFERON-CMV 和监测预测移植受者的巨细胞病毒、死亡率和移植物抗宿主病。
J Med Virol. 2023 Nov;95(11):e29250. doi: 10.1002/jmv.29250.
4
Spontaneously-resolving episodes of cytomegalovirus DNAemia in allogeneic hematopoietic stem cell transplant recipients: Virological features and clinical outcomes.异基因造血干细胞移植受者中自发消退的巨细胞病毒血症发作:病毒学特征和临床结局。
J Med Virol. 2019 Jun;91(6):1128-1135. doi: 10.1002/jmv.25426. Epub 2019 Feb 20.
5
Clinical assessment of anti-viral CD8+ T cell immune monitoring using QuantiFERON-CMV® assay to identify high risk allogeneic hematopoietic stem cell transplant patients with CMV infection complications.采用 QuantiFERON-CMV® assay 进行抗病毒 CD8+ T 细胞免疫监测,以识别具有 CMV 感染并发症的高危异基因造血干细胞移植患者的临床评估。
PLoS One. 2013 Oct 11;8(10):e74744. doi: 10.1371/journal.pone.0074744. eCollection 2013.
6
Ex vivo monitoring of human cytomegalovirus-specific CD8(+) T-Cell responses using the QuantiFERON-CMV assay in allogeneic hematopoietic stem cell transplant recipients attending an Irish hospital.采用 QuantiFERON-CMV assay 对爱尔兰医院的异基因造血干细胞移植受者进行人巨细胞病毒特异性 CD8(+) T 细胞反应的体外监测。
J Med Virol. 2010 Mar;82(3):433-40. doi: 10.1002/jmv.21727.
7
Quantiferon-Cytomegalovirus assay: A potentially useful tool in the evaluation of CMV-specific CD8+ T-cell reconstitution in pediatric hematopoietic stem cell transplant patients.巨细胞病毒定量干扰素检测:评估小儿造血干细胞移植患者中巨细胞病毒特异性CD8 + T细胞重建的一种潜在有用工具。
Pediatr Transplant. 2018 Aug;22(5):e13220. doi: 10.1111/petr.13220. Epub 2018 May 18.
8
Assessing the risk of CMV reactivation and reconstitution of antiviral immune response post bone marrow transplantation by the QuantiFERON-CMV-assay and real time PCR.通过 QuantiFERON-CMV 检测和实时 PCR 评估骨髓移植后 CMV 再激活和抗病毒免疫应答重建的风险。
J Clin Virol. 2018 Feb-Mar;99-100:61-66. doi: 10.1016/j.jcv.2018.01.002. Epub 2018 Jan 9.
9
Incidence, features, and outcomes of cytomegalovirus DNAemia in unmanipulated haploidentical allogeneic hematopoietic stem cell transplantation with post-transplantation cyclophosphamide.在采用移植后环磷酰胺的非处理单倍体相合异基因造血干细胞移植中巨细胞病毒血症的发生率、特征及结局
Transpl Infect Dis. 2020 Feb;22(1):e13206. doi: 10.1111/tid.13206. Epub 2019 Nov 15.
10
The clinical and economic impact of cytomegalovirus infection in recipients of hematopoietic stem cell transplantation.巨细胞病毒感染对造血干细胞移植受者的临床及经济影响。
Transpl Infect Dis. 2018 Oct;20(5):e12961. doi: 10.1111/tid.12961. Epub 2018 Jul 20.

引用本文的文献

1
QuantiFERON Monitor Test as a Potential Tool for Stratifying Patients by Infection Risk and Tailoring Follow-Up Care in Lung Transplant Recipients: A Single-Center Retrospective Experience.全血γ干扰素释放试验作为根据感染风险对肺移植受者进行分层并定制后续护理的潜在工具:单中心回顾性经验
Microorganisms. 2025 Feb 1;13(2):316. doi: 10.3390/microorganisms13020316.